Perinatal asphyxia partly affects presepsin urine levels in non-infected term infants

Abstract Objectives Standard of care sepsis biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT) can be affected by several perinatal factors, among which perinatal asphyxia (PA) has a significant role. In this light, new early sepsis biomarkers such as presepsin (P-SEP) are needed to enact therapeutic strategies at a stage when clinical and laboratory patterns are still silent or unavailable. We aimed at investigating the potential effects of PA on longitudinal P-SEP urine levels. Methods We conducted an observational case-control study in 76 term infants, 38 with PA and 38 controls. Standard clinical, laboratory, radiological monitoring procedures and P-SEP urine measurement were performed at four time-points (first void, 24, 48, 96 h) after birth. Results Higher (p<0.05) CRP and PCT blood levels at T1–T3 were observed in PA than control infants whilst no differences (p>0.05, for all) at T0 were observed between groups. P-SEP urine levels were higher (p<0.05) in PA at first void and at 24 h while no differences (p>0.05) at 48 and 96 h were observed. No significant correlations were found (p>0.05) between P-SEP and urea (R=0.11) and creatinine (R=0.02) blood levels, respectively. Conclusions The present results, showed that PA effects on P-SEP were limited up to the first 24 h following birth in absence of any kidney function bias. Data open the way to further investigations aimed at validating P-SEP assessment in non-invasive biological fluids as a reliable tool for early EOS and LOS detection in high-risk infants.

[1]  A. Manea,et al.  Basic biochemical and hematological parameters in perinatal asphyxia and their correlation with hypoxic ischemic encephalopathy. , 2021, Experimental and therapeutic medicine.

[2]  N. Abdelaal,et al.  The Utility of Neutrophil CD64 and Presepsin as Diagnostic, Prognostic, and Monitoring Biomarkers in Neonatal Sepsis , 2020, International journal of microbiology.

[3]  Chang Seop Lee,et al.  Development of Monitoring System for Assessing Rheumatoid Arthritis within 5 Minutes Using a Drop of Bio-Fluids , 2020, Journal of clinical medicine.

[4]  Manar G Gebriel,et al.  Evaluation of Procalcitonin, C-Reactive Protein, and Interleukin-6 as Early Markers for Diagnosis of Neonatal Sepsis , 2020, International journal of microbiology.

[5]  L. Boni,et al.  Reference ranges of Presepsin in preterm infants in the first 48 hours of life: a multicenter observational study. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[6]  K. Allegaert,et al.  Improved pathogen detection in neonatal sepsis to boost antibiotic stewardship. , 2020, Future microbiology.

[7]  A. Satriano,et al.  Early predictors of perinatal brain damage: the role of neurobiomarkers , 2019, Clinical chemistry and laboratory medicine.

[8]  M. Yalaz,et al.  Reference ranges of presepsin (soluble CD14 subtype) in term and preterm neonates without infection, in relation to gestational and postnatal age, in the first 28 days of life. , 2019, Clinical biochemistry.

[9]  Iris van Maldeghem,et al.  Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis , 2019, BMC Immunology.

[10]  H. Ishikura,et al.  Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[11]  T. Yokoo,et al.  Prediction of presepsin concentrations through commensurate decline in kidney function in the elderly. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[12]  I. Mekjavic,et al.  Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity , 2018, Front. Physiol..

[13]  J. Ashworth,et al.  Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..

[14]  K. Kiselev,et al.  Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study , 2018, Front. Neurol..

[15]  L. Chalak.  Inflammatory Biomarkers of Birth Asphyxia. , 2016, Clinics in perinatology.

[16]  F. Mosca,et al.  Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates , 2015, PloS one.

[17]  Jiayuan Wu,et al.  Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis , 2015, PloS one.

[18]  M. Ando,et al.  Clinical Impact of Kidney Function on Presepsin Levels , 2015, PloS one.

[19]  A. Zea-Vera,et al.  Challenges in the diagnosis and management of neonatal sepsis. , 2015, Journal of tropical pediatrics.

[20]  Francesca Pluchinotta,et al.  Neurological Abnormalities in Full-Term Asphyxiated Newborns and Salivary S100B Testing: The “Cooperative Multitask against Brain Injury of Neonates” (CoMBINe) International Study , 2015, PloS one.

[21]  Yvonne W Wu,et al.  Neonatal Encephalopathy and Neurologic Outcome, Second Edition , 2014, Pediatrics.

[22]  B. Stoll,et al.  Neonatal sepsis: progress towards improved outcomes. , 2014, The Journal of infection.

[23]  Weng-Lang Yang,et al.  Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia , 2013, Brain Research.

[24]  M. Mussap,et al.  Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[25]  G. Li Volti,et al.  Biomarkers of brain damage in preterm infants , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[26]  E. Bertino,et al.  Neonatal growth charts , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[27]  F. Michetti,et al.  Perinatal asphyxia: kidney failure does not affect S100B urine concentrations. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[28]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[29]  M. Frid,et al.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. , 2006, The American journal of pathology.

[30]  T. Ichiyama,et al.  NF‐κB activation in peripheral blood mononuclear cells in neonatal asphyxia , 2003 .

[31]  J. Sarafidou,et al.  Inflammatory mediators in perinatal asphyxia and infection , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[32]  R. Strauss.  Neonatal anemia: pathophysiology and treatment. , 1995 .

[33]  B. Pedersen,et al.  Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutrocytes, natural killer cells, and cytokines. , 1993, Journal of applied physiology.

[34]  H. Sarnat,et al.  Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. , 1976, Archives of neurology.